Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The N.V. Nutricia patent solves the following problem:

During the common process of nutrition in food proteins presented to the immune system through the gastro-intestinal tract without an immune response to ingested nutrients. This unresponsiveness is called oral immune tolerance or oral tolerance. The induction of oral immune tolerance is especially relevant for children, after being exposed for the first time to eat protein and adapt to it. If the children's oral immune tolerance is established, food allergies occur. The people who suffer from food allergies requires a specific food protein food to avoid.

Our analysis of this patent is as follows:

N.V. Nutricia’s patent US 9060996 B2 deals with Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins.
Composition and the manner in which the child nutrition partially hydrolysed protein and non-digestible oligosaccharides for use in the induction of oral tolerance against the native of dietary protein.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Under trailer aerodynamic control system

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The R Henderson II Robert patent solves the following problem:

This invention relates to the reduction in aerodynamic drag for the transfer of land vehicles; particularly to an improved method and device for reducing the aerodynamic drag and to improved performance and stability of the vehicle on earth by building on and increasing the mass and velocity of the airflow passing under a car.

Our analysis of this patent is as follows:

R Henderson II Robert’s patent US 9045176 B1 deals with Under trailer aerodynamic control system.
One under the trailer flight control system which increases the air mass, organizations and velocity before mounted again airflow direction panel and a rear airflow modifier mounted on a durable and movable way to the location near the under side of a truck trailer before the trailer wheels and axles to better handle the rush of air around the trailer wheel and axle assembly. In operation, the rear mounted airflow modifier collects the airflow from the front mounted modifiers and routs impinging air to exit through the trailer wheel well past the end of the trailer for the controlled road spray and splash while circling brake and running cold and reduces parasitic drag on the trailer as it moves on highway while reducing driver fatigue through improved handling characteristics.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Merck Sharp & Dohme Corp. patent solves the following problem:

Spleen Tyrosine Kinase (SYK) is a protein tyrosine kinase described as a key mediator of immunoreceptor signaling a host of inflammatory cells including mast cells, B-cells, macrophages and neutrophils. These immunoreceptors, including Fc receptor and the B-cell receptor, is important for allergic diseases, and antibody-mediated autoimmune diseases and thus pharmacologically interfering SYK conceivably treat these diseases.

Our analysis of this patent is as follows:

Merck Sharp & Dohme Corp.’s patent US 9006444 B2 deals with Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors.
invention provides certain phenyl formamide-containing compounds of Formula (I); or pharmaceutically acceptable salts thereof, wherein A and B as described here. invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated spleen tyrosine kinase (SYK) kinase.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Secure virtualization environment bootable from an external media device

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Citrix Systems, Inc. patent solves the following problem:

As the number of mobile employees, remote employees, guests and employees role-based employees increases, so the demand for computing systems that restrict the information contained in each type of employee, and shut personal data an employee from the work-related data. Many companies give their employees with laptops, remote access to the company Intranet, remote access to applications used by an employee, remote access to files on an employee, and access to remote desktop, virtual machine, or remote applications. In many instances, employees have access to company resources from any location, using any machine and / or network.

Our analysis of this patent is as follows:

Citrix Systems, Inc.’s patent US 8924703 B2 deals with Secure virtualization environment bootable from an external media device.
Methods and systems for creating a secure virtualization environment on a host of devices, without modification to the host device, secure virtualization environment bootable from an external media device. A host of computation load device and boots on a common operating system image stored on an external media device. A client agent stored on external media device and comply with the common operating system creates an adapted operating system image by copying the operating system of the device hosts Computing, removing all unnecessary files and data and storing the adapted operating system images on external media device. The host computing device provides a secure virtualized environment by pregnant adapted operating system images.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Lid for closing a cup

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Constantia Teich Gmbh patent solves the following problem:

Our analysis of this patent is as follows:

Constantia Teich Gmbh’s patent US 8905251 B2 deals with Lid for closing a cup.
A lid (2) for the end of a cup (1) by a peripheral sealing edge (10) and a method for the production of such a lid. lid includes at least one aluminum film and an optionally multi-layered plastic layer that is co-extruded film to aluminum and has a closed predetermined tear lines (3). The plastic layer made of plastic based on polyethylene (PE) or plastic based on polypropylene (PP), and the predetermined tearing line introduced into the plastic layer preferably with a CO2 laser. The predetermined tear lines (3) can be given directly to the sealing edge region (10).

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

User interface with screen spanning icon morphing

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Z124 patent solves the following problem:

While the computing and communications functions for handheld devices Computing becomes more powerful, the user interface and display elements such devices have evolved by trying to adapt user interface regime for the personal computer for use in handheld devices Computing . However, this attempt to adapt the user interface of the regime met with various obstacles.

Our analysis of this patent is as follows:

Z124’s patent US 8842080 B2 deals with User interface with screen spanning icon morphing.
Methods and apparatus for indicating a state of an application that displayable on one or more displays in a handheld device Computing. An icon will be given showing the position and / or the potential application statuses (for example, if the application is expandable and / or expanded). The image may be movable between a first position and a second position depending on the status of applications. The icon changes from the first state to the second state becomes animation with a live or change applications in the display state. Thus, a user can carry the icon to determine the status of the application with respect to one or more displays (for example, if the application is expandable, expanded, or expansion).

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Antibodies to human -adrenergic receptor kinase

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Incyte Corporation patent solves the following problem:

Change protein phosphorylation is ubiquitous methods used to control many of intracellular events in eukaryotic cells. It is estimated that more than ten percent of the active protein in a typical mammal cell are phosphorylated. Kinases to facilitate the transfer of high-energy phosphate group from adenosine triphosphate (ATP) to the target protein hydroxyamino acid residues serine, threonine, or tyrosine. Phosphatases, in contrast, take the phosphate groups. Extracellular signal including hormone; neurotransmitter, growth and inequality factors may activate kinases, which takes place as the cell surface of cells or as activator in the final effector proteins, as well as other places along the way signal transduction. Cascade of kinases occur, as well as sensitive kinases second messenger molecules. This system allows for equipment to amplify the weak signal (lower abundance of growth factor molecules, for example), as well as the synthesis of many weak signal into an all-or-nothing answer. Phosphatases, then, is necessary to determine the extent of phosphorylation in cells and, with kinases, controlling key cellular processes such as metabolic enzyme activity, proliferation, cell growth and inequality, cell adhesion, and cell cycle progression.

Our analysis of this patent is as follows:

Incyte Corporation’s patent US 8779106 B2 deals with Antibodies to human -adrenergic receptor kinase.
Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also giving expression vector, host cells, antibodies, agonists and antagonists. Some embodiments provide methods for diagnosing, treating, or preventing diseases associated with aberrant expression of KPP.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Endpoint-hosted hypervisor management

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The International Business Machines Corporation patent solves the following problem:

The invention relates to the electronic network. Particularly, the invention relates to the endpoint host hypervisor management.

Our analysis of this patent is as follows:

International Business Machines Corporation’s patent US 8677358 B2 deals with Endpoint-hosted hypervisor management.
A client hypervisor consists of a virtual agent that runs out of a system of the OS, and that allows to manage devices independent of the OS and the user. The virtual agents tied to one device and not to a specific time of the OS. Such client hypervisors expose new functionality to ease system management. Some of these capabilities from endurance and privileges without the OS. In some embodiments of the invention, this new management functionality to spread the rule of the device with new virtualization concepts, such as the number of VMs per system, VM instead, snapshot / rollback, etc.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nutrition with lipids and non-digestible saccharides

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The N. V. Nutricia patent solves the following problem:

The gut barrier lines in the gastro-intestinal tract and separates the luminal, outside of the body from the systemic, internal organ. It protects the body from entering the luminal enemies, such as antigens, toxins and pathogens. The gut barrier consists of intestinal epithelium, a continuous monolayer pillars of epithelial cells, enterocytes, bound by protein complexes, such as tight junctions. A tenuous gut barrier function in children, where the gut before maturated enough. Also malnourished people, the patients fasted for surgery and intensive care patients the gut barrier disrupted.

Our analysis of this patent is as follows:

N. V. Nutricia’s patent US 8241659 B2 deals with Nutrition with lipids and non-digestible saccharides.
The invention relates to a liquid nutrition containing short chain fatty acyl chains and a non-digestible, give a saccharide. composition is particularly suitable for use as a child nutrition. composition is suitable for the treatment and / or prevention of gut barrier related diseases.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Data accuracy filter for integrated emergency medical transportation database system

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Golden Hour Data Systems, Inc. patent solves the following problem:

This invention relates to an integrated system of medical database. More specifically, this invention relates to a filter data accuracy for a medical database of emergency medical transportation industry.

Our analysis of this patent is as follows:

Golden Hour Data Systems, Inc.’s patent US 7778849 B1 deals with Data accuracy filter for integrated emergency medical transportation database system.
An integrated medical database system for business emergency medical transportation. The system includes a dispatch module, clinical module, administration module and billing module. Each module to communicate data with one or more other modules to form a system for use in data sharing, thus achieving an end-to-end automation emergency care in medical accounting. Internal consistency checks on the use of specific libraries to amend the rules on data made by the system to ensure that proper treatments made according to a choice diagnosis. The system includes a demographic filter the data the proper functioning of patient data by the billing module.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.